Effects of acute paroxetine administration on tryptophan metabolism and disposition in the rat
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The effects of acute oral administration of paroxetine on tryptophan metabolism and disposition were examined in the rat. Basal liver tryptophan pyrrolase activity was inhibited by paroxetine in vitro and after oral administration. Maximum inhibition was caused by a 1 mg kg−1 dose. Paroxetine administration also inhibited pyrrolase activity that had previously been enhanced by hormonal induction by cortisol or cofactor activation by haematin. The cortisol induction of the enzyme was, however, not inhibited by pretreatment of rats with paroxetine. Paroxetine increased tryptophan availability to the brain, because of the above pyrrolase‐inhibitory mechanism. Cerebral 5‐hydroxytryptamine (5‐HT) synthesis was accordingly enhanced, though this was apparent only with doses of the drug of up to 1 mg kg−1. With larger doses, decreased 5‐HT turnover, probably as a result of 5‐HT uptake inhibition, was the more dominant feature. Paroxetine lowered circulating corticosterone concentration, but did not influence those of albumin, non‐esterified fatty acids or glucose. It is concluded that, in addition to inhibiting brain 5‐HT turnover, paroxetine also, in common with 20 other antidepressants, enhances 5‐HT synthesis by increasing brain tryptophan concentration secondarily to inhibition of liver tryptophan pyrrolase activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Carlsson, A., & Lindqvist, M. (1978) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00508062 · Cited by 326
Cited by
Kelly, J. R., Borre, Y., O' Brien, C., Patterson, E., El Aidy, S., Deane, J., Kennedy, P. J., Beers, S., Scott, K., Moloney, G., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.07.019 · Cited by 1,683
“The rate of tryptophan metabolism along the kynurenine pathway is dependent on the activity of indoleamine-2, 3-dioxygenase (IDO), an enzyme induced by cytokines, and tryptophan-2,3-dioxygenase (TDO), the expression of which can be induced by circulating glucocorticoids (O'Connor et al., 2009) and has been reported to…”
BackgroundRole of brain-derived neurotrophic factor in Huntington's disease
ZUCCATO, C., & CATTANEO, E. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.01.003 · Cited by 552
Tryptophan metabolism in the central nervous system: medical implications
Ruddick, J. P., Evans, A. K., Nutt, D. J., Lightman, S. L., Rook, G. A. W., & Lowry, C. A. (2006) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399406000068 · Cited by 519
Interferon-alpha–induced changes in tryptophan metabolism
Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00173-2 · Cited by 493
Quak, J., Doornbos, B., Roest, A. M., Duivis, H. E., Vogelzangs, N., Nolen, W. A., Penninx, B. W. J. H., Kema, I. P., & de Jonge, P. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.013 · Cited by 98
“, 2012) and might influence KYN/TRP by inhibiting tryptophan 2,3-dioxygenase (TDO) another enzyme that converts TRP into KYN (Ara and Bano, 2012; Badawy and Morgan, 1991).”
Background
Metadata
- Authors
- Badawy, A. A. ‐., & Morgan, C. J.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1991-02
- Volume
- 102
- Issue
- 2
- Pages
- 429-433
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2005352849
- Cited by
- 39
- References
- 1
- FWCI
- 0.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of acute paroxetine administration on tryptophan metabolism and disposition in the rat. https://app.cochat.ai/papers/10.1111/j.1476-5381.1991.tb12190.x
- The paper
- Badawy, A. A. ‐., & Morgan, C. J. (1991). Effects of acute paroxetine administration on tryptophan metabolism and disposition in the rat. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1991.tb12190.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.